Chicago · Independent Healthcare AI Publication
A clinician's read on healthcare AI.
One briefing a week. Free. No vendor pitch.
Briefing No. 34 · Telepharmacy
Ohio's August 2026 rules set a 99.985% accuracy gate for machines that dispense without a pharmacist. Its 45-day window cannot resolve that number.
CMS created a standalone Medicare payment category for clinical software in July 2026. The section is titled SaMS Diagnostic Services, and pharmacy AI is not in it.
No. 32 · Medical AffairsFDA's own guidance says confidentiality of interim results decides whether a trial is adequate and well-controlled. Its real-time trials pipe signals out mid-study.
No. 31 · Clinical AIHouston Methodist called its Apella OR-AI study independent proof of a surgery-volume gain. The paper's own significance test falls short at p=0.182.
Where AI is actually changing pharmacy, clinical operations, and medical affairs, plus the regulation moving underneath it.
TheraIntel is shorthand for therapeutic intelligence: clinical judgment brought to the AI reshaping pharmacy and care. It is an independent publication covering AI across pharmacy, telepharmacy, clinical operations, and medical affairs, written by Shan Siddique, PharmD, a practicing clinical pharmacist with over a decade of frontline healthcare operations experience.
The healthcare AI conversation is loud, and most of it is written by people who have never verified an order, run a pharmacist schedule, or briefed a clinician on the evidence. This is the operator's read: what the technology actually does, what the regulation actually says, and what it means for the people doing the work.
TheraIntel is an independent publication. The analysis here is editorial, written on personal time, and the views expressed are the author's own. They do not represent any employer.
More about TheraIntel →A clinician's analysis of the AI moves reshaping pharmacy, clinical operations, and medical affairs, plus the regulation moving underneath them. Built for operators, not the hype cycle.
Join the list and get the briefing in your inbox. No spam, unsubscribe anytime.
By subscribing you agree to receive email updates from TheraIntel. We never sell or share your address.